Delivery Order SPE2DB20D2014-SPE2DB25FB72M

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.34 firm fixed-price delivery order is for the supply of Morphine Sulfate Immediate Release 15 mg tablets. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, which enables AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,600.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
This federal contract award, identified as SPE2DX22D0010|SPE2D825FBE89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,682.83 firm fixed-price delivery order is for the supply of 30mg Morphine Sulfate Extended-Release capsules, with a performance period running through November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,140.71 for the supply of 4 mg/mL Morphine Sulfate vials. The contract is placed by the Defense Logistics Agency (DLA), a defense agency that provides medical products and supplies to military treatment facilities and other federal healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,769.66 Firm Fixed Price delivery order is for the supply of Morphine Sulfate Extended Release (ER) 60mg capsules. The contract has an ultimate completion date of January 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,826,531 units of Morphine Sulfate 100 mg/5 ml concentrated solution in 120 ml containers, with a ceiling value of $1,179.14. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is valued at $2,371.80 and has a completion date of February 7, 2024. The award is to provide Morphine Sulfate 10 mg/mL vials to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,714,149 units of Morphine Sulfate ER 20 mg capsules in 100-count bottles. The contract has a completion date of February 21, 2024 and a potential value of $3,119.03. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to Amerisourcebergen Drug Corporation for $53,800. The firm fixed price order is to provide 100 count bottles of 30mg Morphine Sulfate ER tablets to a facility in Conshohocken, Pennsylvania. Performance will take place between September 8-11, 2023. As a major provider of pharmaceuticals to the Department of Defense, this order supports the Agency's mission to procure necessary medical supplies for the...
This federal contract award is a delivery order valued at $1,329.30 for the supply of MORPHINE 10 MG/ML CARPUJECT ML to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB72M
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,266.82 for the supply of 4568013007 - Morphine Sulf ER 15 mg Tablet UD 100s. The award has an ultimate completion date of April 24, 2025.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award described is not designated as a set-aside.

Generated 7/23/25, 10:03 AM